LCTX Lineage Cell Therapeutics Inc: Accounting Value per Share

Graphic logo of Lineage Bio (LCTX)

As reflected in the pakistan chart, the asset value of Lineage Cell Therapeutics (LCTX) on GURU.Markets is 0.24, illustrating the price action of this biotech firm focused on vision and CNS recovery for injured patients. However, investments are extremely risky due to prolonged product time-to-market and stringent regulatory oversight. Operational stability is maintained by outsourcing the transport of biomaterials to specialized carriers under strict internal monitoring.

Lineage Corp - LCTX Net Assets per Share (period 07/04/2022 - 10/27/2026)

lineagecell.com - analytical breakdowns and key metrics (LCTX)

- price and consensus price forecast:
Stock Quotes Lineage Bio|LCTX - Analyst Forecast Prices
- market capitalization data:
Market Valuation Lineage Cell Therapeutics, Inc.|LCTX - Business Value
- book capitalization data:
Net Assets per Single Share Lineage Cell Therapeutics|LCTX - Book Valuation of Business|Market Cap to Net Assets Ratio lineagecell.com|LCTX - Aggregate Business Assets
- debt and liquidity data:
Total Debt to Capital Lineage Cell Therapeutics|LCTX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Lineage Cell Therapeutics, Inc.|LCTX - Company Total Debt|Debts to Book Capitalization Lineage Cell Therapeutics, Inc.
Analysis of all company metrics:Lineage Bio - LCTX
Finished products of Lineage Cell Therapeutics, Inc.

Investing in Lineage Cell Therapeutics (LCTX) requires strict fundamental oversight, as the book value per share determines the residual value of the company's assets minus all liabilities. By analyzing the current book value per share on GURU.Markets, an investor can identify the actual capital reserve, which, amid pre-revenue R&D trials and rising biomaterial costs, serves as the sole guarantor of the issuer's financial stability.

Competitors of Lineage Cell Therapeutics (LCTX)

Accounting Value per Share Mesoblast Corp MESO|Surrozen Inc. (SRZN) - Book Price of a Share|Accounting Value per Share cryo-cell.com|FBLG (FibroBiologics) - Equity per Share|LGVN: Net Assets per Single Share|Net Assets per Share BioRestorative (BRTX)|Accounting Value per Share Creative Medical Technology